[{"title": "Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model", "link": "https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf324/8139707", "details": "T Baka, J Moore, F Qin, SR Yurista, A Zhang, H He\u2026 - European Heart Journal, 2025", "abstract": "Abstract Background and Aims Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder characterized by left ventricular hypertrophy (LVH), diastolic dysfunction, and impaired metabolic efficiency. This study investigates the \u2026"}]
